1. Home
  2. CGEM vs ZKH Comparison

CGEM vs ZKH Comparison

Compare CGEM & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • ZKH
  • Stock Information
  • Founded
  • CGEM 2016
  • ZKH 1998
  • Country
  • CGEM United States
  • ZKH China
  • Employees
  • CGEM N/A
  • ZKH N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • ZKH
  • Sector
  • CGEM Health Care
  • ZKH
  • Exchange
  • CGEM Nasdaq
  • ZKH Nasdaq
  • Market Cap
  • CGEM 530.0M
  • ZKH 496.1M
  • IPO Year
  • CGEM 2021
  • ZKH 2023
  • Fundamental
  • Price
  • CGEM $7.50
  • ZKH $3.07
  • Analyst Decision
  • CGEM Strong Buy
  • ZKH Buy
  • Analyst Count
  • CGEM 5
  • ZKH 1
  • Target Price
  • CGEM $30.00
  • ZKH $4.00
  • AVG Volume (30 Days)
  • CGEM 371.7K
  • ZKH 20.4K
  • Earning Date
  • CGEM 08-07-2025
  • ZKH 08-21-2025
  • Dividend Yield
  • CGEM N/A
  • ZKH N/A
  • EPS Growth
  • CGEM N/A
  • ZKH N/A
  • EPS
  • CGEM N/A
  • ZKH N/A
  • Revenue
  • CGEM N/A
  • ZKH $1,217,705,644.00
  • Revenue This Year
  • CGEM N/A
  • ZKH $11.72
  • Revenue Next Year
  • CGEM N/A
  • ZKH $10.57
  • P/E Ratio
  • CGEM N/A
  • ZKH N/A
  • Revenue Growth
  • CGEM N/A
  • ZKH 2.24
  • 52 Week Low
  • CGEM $6.85
  • ZKH $2.50
  • 52 Week High
  • CGEM $21.01
  • ZKH $4.10
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 41.43
  • ZKH 55.19
  • Support Level
  • CGEM $7.53
  • ZKH $3.00
  • Resistance Level
  • CGEM $9.25
  • ZKH $3.19
  • Average True Range (ATR)
  • CGEM 0.38
  • ZKH 0.21
  • MACD
  • CGEM -0.13
  • ZKH 0.00
  • Stochastic Oscillator
  • CGEM 13.02
  • ZKH 87.23

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Share on Social Networks: